On the eve of Zoom's earnings call, it appears they have stabilized. However, the real lesson lies in navigating a bubble – distinguishing genuine hype and expansion from mere speculation.
This leads me to ponder the evaluation and potential justification of stocks like NVDA, LLY, and NVO, which currently seem isolated. Can their pricing be substantiated?
While I cannot comment on NVDA, regarding LLY, I'd confident that most overweight people would kill to be thinner. The weight loss industry is worth 300 Billion globally.
Although I don't hold NVDA, I do have BOTZ, an AI ETF where NVDA comprises around 10% of the portfolio. If NVDA experiences a surge post-earnings, I may consider derisking.
Looking ahead, my trust lies primarily in SPY and QQQ over the next decade. There's no need for excessive greed, especially given the remarkable movement of QQQ.